DEUCRAVACITINIB

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Details

Stereochemistry	ACHIRAL
Molecular Formula	C20H22N8O3
Molecular Weight	425.459
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure of DEUCRAVACITINIB

Structure Search

SMILES

[2H]C([2H])([2H])NC(=O)C1=C(NC2=CC=CC(C3=NN(C)C=N3)=C2OC)C=C(NC(=O)C4CC4)N=N1

InChI

InChIKey=BZZKEPGENYLQSC-FIBGUPNXSA-N

InChI=1S/C20H22N8O3/c1-21-20(30)16-14(9-15(25-26-16)24-19(29)11-7-8-11)23-13-6-4-5-12(17(13)31-3)18-22-10-28(2)27-18/h4-6,9-11H,7-8H2,1-3H3,(H,21,30)(H2,23,24,25,29)/i1D3

HIDE SMILES / InChI

Molecular Formula	C20H22N8O3
Molecular Weight	425.459
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Approval Year

Substance Class	Chemical Created by `admin` on `Sat Dec 16 12:53:21 UTC 2023` Edited by `admin` on `Sat Dec 16 12:53:21 UTC 2023`
Record UNII	N0A21N6RAU
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

DEUCRAVACITINIB

Official Name

English

6-((CYCLOPROPYLCARBONYL)AMINO)-4-((2-METHOXY-3-(1-METHYL-1H-1,2,4-TRIAZOL-3-YL)PHENYL)AMINO)-N-(2H3)METHYL-3-PYRIDAZINE-CARBOXAMIDE

Systematic Name

English

Deucravacitinib [WHO-DD]

Common Name

English

DEUCRAVACITINIB [JAN]

Common Name

English

DEUCRAVACITINIB [USAN]

Common Name

English

3-PYRIDAZINECARBOXAMIDE, 6-((CYCLOPROPYLCARBONYL)AMINO)-4-((2-METHOXY-3-(1-METHYL-1H-1,2,4-TRIAZOL-3-YL)PHENYL)AMINO)-N-(METHYL-D3)-

Systematic Name

English

BMS-986165

Common Name

English

SOTYKTU

Brand Name

English

deucravacitinib [INN]

Common Name

English

Code System Code Type Description

FDA UNII

N0A21N6RAU

Created by admin on Sat Dec 16 12:53:22 UTC 2023 , Edited by admin on Sat Dec 16 12:53:22 UTC 2023

PRIMARY

RXCUI

2612087

Created by admin on Sat Dec 16 12:53:22 UTC 2023 , Edited by admin on Sat Dec 16 12:53:22 UTC 2023

PRIMARY

CAS

1609392-27-9

Created by admin on Sat Dec 16 12:53:22 UTC 2023 , Edited by admin on Sat Dec 16 12:53:22 UTC 2023

PRIMARY

DAILYMED

N0A21N6RAU

Created by admin on Sat Dec 16 12:53:22 UTC 2023 , Edited by admin on Sat Dec 16 12:53:22 UTC 2023

PRIMARY

INN

11342

Created by admin on Sat Dec 16 12:53:22 UTC 2023 , Edited by admin on Sat Dec 16 12:53:22 UTC 2023

PRIMARY

USAN

FG-51

Created by admin on Sat Dec 16 12:53:22 UTC 2023 , Edited by admin on Sat Dec 16 12:53:22 UTC 2023

PRIMARY

SMS_ID

300000021803

Created by admin on Sat Dec 16 12:53:22 UTC 2023 , Edited by admin on Sat Dec 16 12:53:22 UTC 2023

PRIMARY

NCI_THESAURUS

C174730

Created by admin on Sat Dec 16 12:53:22 UTC 2023 , Edited by admin on Sat Dec 16 12:53:22 UTC 2023

PRIMARY

PUBCHEM

134821691

Created by admin on Sat Dec 16 12:53:22 UTC 2023 , Edited by admin on Sat Dec 16 12:53:22 UTC 2023

PRIMARY

Related Record Type Details


					47RRR83SK7

INTERFERON ALFA-2A

TARGET -> INHIBITOR

Comments:

INTERFERON STIMULATED REPORTER GENE ASSAY

Interaction Type:

DOWNSTREAM INHIBITOR

Amount:


					7B590791ER

INTERLEUKIN-12 HUMAN

TARGET -> INHIBITOR

Interaction Type:

DOWNSTREAM INHIBITOR

Amount:


					IU9PU6XOB6

IL-23

TARGET -> INHIBITOR

Comments:

IL-23 STIMULATED REPORTER GENE ASSAY

Interaction Type:

DOWNSTREAM INHIBITOR

Amount:


					V094BEF0W8

NON-RECEPTOR TYROSINE-PROTEIN KINASE TYK2

TARGET -> INHIBITOR

Comments:

Tyk2 JH2 ligand

Qualification:

IC50

Amount:


					V094BEF0W8

NON-RECEPTOR TYROSINE-PROTEIN KINASE TYK2

TARGET -> INHIBITOR

Qualification:

Ki

Amount:


					6D53G0FD0Z

PLASMA PROTEIN FRACTION (HUMAN)

BINDER->LIGAND

Interaction Type:

BINDING

Amount:

95C5558CF4

DEUCRAVACITINIB HYDROCHLORIDE

SALT/SOLVATE -> PARENT

Amount:

Related Record Type Details


					N0A21N6RAU

DEUCRAVACITINIB

ACTIVE MOIETY

Amount: